Company Overview - Assembly Biosciences, Inc. is a biotechnology company focused on developing innovative small-molecule therapeutics aimed at serious viral diseases, including herpesvirus, hepatitis B virus (HBV), and hepatitis delta virus (HDV) infections [2] Upcoming Event - Jason Okazaki, CEO, and Anuj Gaggar, CMO, will present in a fireside chat at the Jefferies 2025 Global Healthcare Conference on June 4, 2025, at 8:45 a.m. Eastern Time [1] - A live webcast of the event will be available on Assembly Bio's website, with a replay accessible afterward [1] Leadership and Commitment - The company is led by a team experienced in virologic drug development, demonstrating a commitment to improving patient outcomes affected by chronic viral infections [2]